Earkart

  • Market Cap: N/A
  • Industry: Healthcare Services
  • ISIN: INE1A8F01035
  • NSEID:
  • BSEID: 544549
INR
126.40
-3.6 (-2.77%)
BSENSE

Jun 18

BSE+NSE Vol: 8000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

8.0 k (300.00%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

21.95%

Held by 0 DIIs

Promoter

57.34%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 186 Cr ()

stock-summary
P/E

36.00

stock-summary
Industry P/E

93

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

2.78

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.33%
0%
5.33%
6 Months
-31.21%
0%
-31.21%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Earkart for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Announcement under Regulation 30 (LODR)-Acquisition

30-May-2026 | Source : BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended and read with schedule III of aforesaid regulations dated 30 January 2026 the Board of Directors of the Company in their meeting held on 29 May 2026 has inter alia approved the incorporation of a wholly owned subsidiary by the name Earkart Pharmaceuticals Private Limited and Earkart Healthcare Services Private Limited.

Declaration Pursuant To Regulation 33(3)(D) Of The SEBI(Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended In Respect Of Audit Report With Unmodified Opinion For The Financial Year Ended 31 March 2026

29-May-2026 | Source : BSE

The statutory auditor of the Company M/s Timsi & Associates Chartered Accountants has issued Audit Report with unmodified opinion on the Audited Fiancial Results of the Company for the half yearly ended and yearly ended 31 March 2026.

Board Meeting Outcome for Outcome Of Board Meeting Dated 29 May 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015

29-May-2026 | Source : BSE

The Board of Directors of the Earkart Limited at its meeting held on 29 May 2026 inter alia considered and approved Audited Financial Results for the half year ended and financial year ended 31 March 2026 along with Independent Auditors Report issued by the statutory auditors M/s Timsi & Associates

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
6.80
Debt to EBITDA (avg)
0.58
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.72
Tax Ratio
31.96%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
21.95%
ROCE (avg)
26.47%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
36
Industry P/E
93
Price to Book Value
2.78
EV to EBIT
20.40
EV to EBITDA
18.79
EV to Capital Employed
3.68
EV to Sales
2.91
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
18.05%
ROE (Latest)
7.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
Bollinger Bands
Sideways
KST
Dow Theory
Bearish
Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Rohit Misra (55.04%)

Highest Public shareholder

Neomile Growth Fund- Series -i (16.92%)

Individual Investors Holdings

16.94%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Earkart"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Earkart"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Earkart"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Earkart"
  }
]
stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details